Sale of Securities

Cadrenal Therapeutics, Inc. Filed 2025-10-09 Acc 0001628280-25-044689

Documents 1

2025-10-14 144 Sale of Securities
2025-10-14 4 CEO and Chairman sold 3,600 shares at an average $14.09 ($50,706)
2025-10-14 4 Chief Financial Officer sold 3,493 shares at an average $14.03 ($49,011)
2025-10-09 144 Sale of Securities
2025-10-09 144 Sale of Securities
2025-10-07 4 Chief Financial Officer sold 107 shares at $13.99 ($1,497)
2025-10-06 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…